Currently available versions of genome-wide association studies cannot be used to query the common haptoglobin copy number variant.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

12 citing papers in PubMed.

1. Relationship between time-varying achieved HbABMJ open diabetes research & care · 2025
   Article
2. Assessment of haptoglobin alleles in autism spectrum disorders.Scientific reports · 2020
   Article
3. Haptoglobin Phenotypes Are Associated with the Postload Glucose and Insulin Levels in Pediatric Obesity.International journal of endocrinology · 2020
   Article
4. Meta-analysis of the association of the haptoglobin genotype with cardiovascular outcomes and the pharmacogenomic interactions with vitamin E supplementation.Pharmacogenomics and personalized medicine · 2018
   Article
5. Precision Healthcare of Type 2 Diabetic Patients Through Implementation of Haptoglobin Genotyping.Frontiers in cardiovascular medicine · 2018
   Article
6. Recurring exon deletions in the HP (haptoglobin) gene contribute to lower blood cholesterol levels.Nature genetics · 2016
   Article
7. The Haptoglobin genotype predicts cardio-renal mortality in type 1 diabetes.Journal of diabetes and its complications · 2016
   Article
8. New and emerging biomarkers in cardiovascular disease.Current diabetes reports · 2015
   Review
9. The Risk of Coronary Heart Disease Associated With Glycosylated Hemoglobin of 6.5% or Greater Is Pronounced in the Haptoglobin 2-2 Genotype.Journal of the American College of Cardiology · 2015
   Article
10. Novel metabolic biomarkers of cardiovascular disease.Nature reviews. Endocrinology · 2014
    Review
11. Treatment: Marginal gains.Nature · 2014
    Article
12. Epistasis between the haptoglobin common variant and α+thalassemia influences risk of severe malaria in Kenyan children.Blood · 2014
    Article

Corrections and comments

• Comment on
  Haptoglobin genotype is a consistent marker of coronary heart disease risk among individuals with elevated glycosylated hemoglobin.2013

Authors and funding

6 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as